SLC17A7 and Alzheimer disease: In a previous paper we determined a significant reduction of GFAP expression in the cortex of AD mice following GA or/and GA-MΦ immunotherapy (63), and found GFAP expression in this model was negatively associated with pre-synapse VGluT1.